These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5513444)

  • 1. [Fibrinogen elevation and fibrinolysis in childhood].
    Suschke J
    Kinderarztl Prax; 1970 Mar; 38(3):97-100. PubMed ID: 5513444
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of selected parameters of hemostasis in patients with nephrotic syndrome].
    Rowiński M; Rydzewski A; Małyszko JS; Małyszko J; Myśliwiec M
    Przegl Lek; 1994; 51(2):77-81. PubMed ID: 8058973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood coagulation, fibrinolysis and the mercurial nephrotic syndrome.
    Barr RD; Ouna N; Rees PH
    J Trop Med Hyg; 1976 Oct; 79(10):235-6. PubMed ID: 1011317
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperfibrinolysis and reduced fibrinolytic activity in the thrombelastogram of children].
    Suschke HJ; Kastenbauer E; Kunze D
    Med Monatsschr; 1972 Nov; 26(11):521-3. PubMed ID: 4649529
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypercoagulability, intraglomerular coagulation, and thromboembolism in nephrotic syndrome.
    Sagripanti A; Barsotti G
    Nephron; 1995; 70(3):271-81. PubMed ID: 7477613
    [No Abstract]   [Full Text] [Related]  

  • 6. Postoperative changes in fibrinogen and its fractions.
    Cotton RC; Craven JL
    Surg Gynecol Obstet; 1970 Dec; 131(6):1073-6. PubMed ID: 5479203
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dysfibrinogenemia and nephrotic syndrome: a case report].
    Shigekiyo T; Shirakami A; Kawauchi S; Hirai Y; Takeichi T; Inomoto T; Inoue T; Shintani Y; Takada Y; Mizuguchi Y
    Rinsho Ketsueki; 1985 May; 26(5):761-5. PubMed ID: 4057588
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the relationship between serum cholesterol and plasma fibrinogen].
    Suschke J; Foldenauer A
    Dtsch Med Wochenschr; 1968 Sep; 93(36):1705-7. PubMed ID: 5668263
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum cholesterol and triglycerides in childhood nephrotic syndrome in northern Nigeria. A preliminary report.
    Abdurrahman MB; Suvarnabai PC; Aikhionbare HA; Timoszyk J
    Trop Geogr Med; 1984 Mar; 36(1):7-11. PubMed ID: 6729984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of indices of blood coagulation and anticoagulation systems of the blood in hemorrhagic fever with nephrotic syndrome].
    Kashapova RV
    Ter Arkh; 1968 Mar; 40(3):82-5. PubMed ID: 5669290
    [No Abstract]   [Full Text] [Related]  

  • 11. Nephrotic syndrome. A hypercoagulable state.
    Kendall AG; Lohmann RC; Dossetor JB
    Arch Intern Med; 1971 Jun; 127(6):1021-7. PubMed ID: 5578557
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in several blood coagulation parameters in the nephrotic syndrome].
    Gasparotto ML; Bertoli M; Bertaglia E; Vertolli U; Varchetta V; Favaro P; Rebeschini M; Di Lavoro D; Romagnoli GF
    Minerva Nefrol; 1981; 28(1):15-9. PubMed ID: 6793942
    [No Abstract]   [Full Text] [Related]  

  • 13. [Concentration of tissue plasminogen activator and its inhibitor 1 in cyclosporine A-treated children with idiopathic nephrotic syndrome].
    Tkaczyk M; Owczarek D; Finke D; Nowicki M
    Pol Merkur Lekarski; 2003 Apr; 14(82):315-8. PubMed ID: 12868191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Abnormalities in coagulation and fibrinolysis in septic shock with purpura].
    Sánchez Miralles A; Reig Sáenz R; Marco Vera P; Muñoz Pérez F; Alvarez Sánchez B; Sebastián Muñoz I
    An Esp Pediatr; 2002 Feb; 56(2):99-103. PubMed ID: 11827669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolic risk in children with nephrotic syndrome.
    De Mattia D; Penza R; Giordano P; Di Bitonto G; Altomare M; Del Vecchio GC; Schettini F
    Haemostasis; 1991; 21(5):300-4. PubMed ID: 1806458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotic syndrome and anticoagulant therapy.
    Kaizu K; Etoh S
    Intern Med; 1998 Feb; 37(2):210-2. PubMed ID: 9550613
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clotting factors in the nephrotic syndrome].
    Manny N; Viskoper RJ; Keynan A
    Harefuah; 1972 Oct; 83(7):272-4. PubMed ID: 4669707
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrin-fibrinogen degradation products in children with renal disease.
    Uttley WS; Maxwell H; Cash JD
    Arch Dis Child; 1974 Feb; 49(2):137-42. PubMed ID: 4817446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of serum cholesterol in childhood nephrotic syndrome.
    Okoro BA
    East Afr Med J; 1987 Dec; 64(12):845-8. PubMed ID: 3505207
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cholesterol metabolism in children with idiopathic nephrotic syndrome].
    Stozický F; Liska J; Dobiásová M; Slovácek R
    Cesk Pediatr; 1988 Jun; 43(6):323-6. PubMed ID: 3401965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.